122 completed, 5 active not recruiting, 4 unknown, 3 withdrawn. 137 Phase 3, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 137 | Completed 122, Active not recruiting 5, Unknown 4, Withdrawn 3, Not yet recruiting 1, Recruiting 1, Terminated 1 |
| Phase 2 | 5 | Completed 3, Active not recruiting 1, Withdrawn 1 |
Follow Tetanus: new trials by email Literature Review of Tetanus trials Research Report on Tetanus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of BK1803 in Healthy Infants BK1803, GOBIK Aqueous Suspension Syringes, Bimmugen® Injection - Pertussis, Diphtheria | Phase 3 | Recruiting | Tanabe Pharma Corporation | 344 | 2026-10-21 | 2026-11-12 |
| A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women dTpa - Diphtheria-Tetanus-acellular Pertussis Vaccines | Phase 3 | Active not recruiting | GlaxoSmithKline | 102 | 2026-06-29 | 2026-09-08 |
| A Phase Ⅲ Clinical Study of SNA02-48 Injection SNA02-48, Human tetanus immunoglobulin (HTIG) - Tetanus | Phase 3 | Not yet recruiting | Sinovac Life Sciences Co., Ltd. | 600 | 2026-06-28 | 2026-06-08 |
| A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series LBVD, Pentavalent vaccine and Inactivated Polio vaccine - Diphtheria, Tetanus | Phase 2 / Phase 3 | Active not recruiting | LG Chem | 1186 | 2025-05-30 | 2026-09-03 |
| Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 1), Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 2), Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 3) - Diphtheria, Tetanus and Acellular Pertussis | Phase 3 | Active not recruiting | CanSino Biologics Inc. | 780 | 2025-03-23 | 2025-08-15 |
| A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Tdcp)), 23-valent Pneumococcal Polysaccharide Vaccine (PPV23), Tdcp - Diphtheria, Tetanus | Phase 2 / Phase 3 | Completed | CanSino Biologics Inc. | 1820 | 2024-12-20 | 2026-08-26 |
| A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection GR2001, HTIG - Tetanus | Phase 3 | Unknown | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 582 | 2024-09-03 | 2024-10-10 |
| A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over TTVA, TT - Tetanus | Phase 3 | Completed | CanSino Biologics Inc. | 1000 | 2024-03-20 | 2026-08-05 |
| Phase I/III Clinical Trial of Adsorbed Tetanus Vaccine Tetanus Toxoid (Adsorbed) - Tetanus, Tetanus Vaccine | Phase 3 | Completed | Beijing Minhai Biotechnology Co., Ltd | 1240 | 2024-02-29 | 2026-08-03 |
| Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population Investigational tetanus vaccine, adsorbed, Control tetanus vaccine, adsorbed - Tetanus | Phase 3 | Completed | Sinovac Life Sciences Co., Ltd. | 1260 | 2023-09-01 | 2024-07-12 |
| A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP) Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP), Diphtheria，Tetanus and Acellular Pertussis Combined Vaccine，DTaP, Diphtheria,tetanus,pertussis(acellular,component),Inactivated polio vaccine(adsorbed）and Haemophilus influenzae type b conjugate vaccine,adsorbed,DTaP-IPV-Hib - Diphtheria, Tetanus and Acellular Pertussis | Phase 3 | Active not recruiting | CanSino Biologics Inc. | 2520 | 2023-08-11 | 2025-03-17 |
| Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against Tetanus TNM002, Human tetanus immunoglobulin (HTIG) - Tetanus | Phase 3 | Completed | Zhuhai Trinomab Pharmaceutical Co., Ltd. | 675 | 2022-12-22 | 2026-09-01 |
| Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria. Clodivac, Td-Impfstoff Merieux - Diphtheria, Tetanus | Phase 3 | Unknown | IBSS Biomed S.A. | 200 | 2022-12-12 | 2024-02-05 |
| A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age RSV MAT vaccine, dTpa vaccine - Respiratory Syncytial Virus Infections | Phase 3 | Completed | GlaxoSmithKline | 9 | 2022-02-02 | 2023-04-07 |
| A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed, Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed, Diphtheria,tetanus,pertussis(acellular,component),poliomyelitis(inactivated) vaccine(absorbed) and Haemophilus influenzae type b conjugate vaccine - Whooping Cough, Diphtheria | Phase 3 | Active not recruiting | China National Biotec Group Company Limited | 2898 | 2021-10-22 | 2025-09-15 |
| Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus and Acellular pertussis (Component) Combined Vaccine (Adsorbed), Diphtheria, Tetanus and Acellular pertussis (Component) Combined Vaccine (Adsorbed) - Streptococcus Pneumoniae Infections | Phase 3 | Completed | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 1110 | 2021-09-16 | 2025-02-10 |
| Tdap Vaccine Safety for Plasma Donors Adacel - Tetanus | Phase 2 / Phase 3 | Completed | GCAM Inc. | 110 | 2020-02-03 | 2022-12-06 |
| To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years DTaP-IPV combination vaccine - Diphtheria, Tetanus | Phase 3 | Unknown | Boryung Biopharma Co., Ltd. | 249 | 2019-12-26 | 2020-11-06 |
| Confirmatory Study of BK1310 in Healthy Infants DPT-IPV-Hib, Hib vaccine, DPT-IPV - Tetanus, Diphtheria | Phase 3 | Completed | Tanabe Pharma Corporation | 267 | 2019-04-01 | 2026-01-06 |
| Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series LBVD (Hexavalent vaccine), Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains) - Diphtheria, Tetanus | Phase 2 / Phase 3 | Completed | LG Chem | 60 | 2018-07-18 | 2026-09-03 |
Showing 20 of 137. Sign in to see all of them.
Diphtheria (121) · Whooping Cough (78) · Poliomyelitis (62) · Haemophilus Infections (61) · Hepatitis B (56) · Virus Diseases (6) · Influenza, Human (5) · Meningococcal Infections (5) · Bacterial Infections (4) · Meningitis (3) · Pneumococcal Infections (3) · Measles (2) · Meningitis, Bacterial (2) · Meningitis, Meningococcal (2)
Bacterial Infections and Mycoses (137) · Clostridium Infections (137) · Gram-Positive Bacterial Infections (137) · Infections (137) · Bacterial Infections (133) · Actinomycetales Infections (121) · Corynebacterium Infections (121) · Gram-Negative Bacterial Infections (100) · Virus Diseases (83) · Respiratory Tract Diseases (80) · Respiratory Tract Infections (80) · Bordetella Infections (78) · Nervous System Diseases (66) · Neuroinflammatory Diseases (66) · RNA Virus Infections (66)
Tetanus Toxoid (25) · Diphtheria-Tetanus-acellular Pertussis Vaccines (17) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (17) · Boostrix (14) · Hiberix (11) · adacel (8) · Pentavac (7) · Vaccines, Combined (7) · DTaP-IPV-HB-PRP-T vaccine (6) · Heptavalent Pneumococcal Conjugate Vaccine (6) · pentacel (6) · Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (5) · HibTITER protein, Haemophilus influenzae (5) · Poliovirus Vaccine, Inactivated (5) · 13-valent pneumococcal vaccine (4)
GlaxoSmithKline (59) · Sanofi Pasteur, a Sanofi Company (31) · Sanofi (10) · Merck Sharp & Dohme LLC (7) · CanSino Biologics Inc. (4) · Tanabe Pharma Corporation (3) · Boryung Biopharma Co., Ltd. (2) · Crucell Holland BV (2) · LG Chem (2) · MCM Vaccines B.V. (2) · Novartis Vaccines (2) · Sinovac Life Sciences Co., Ltd. (2) · Beijing Minhai Biotechnology Co., Ltd (1) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (1) · Boryung Pharmaceutical Co., Ltd (1)
China (22) · United States (18) · Philippines (11) · South Korea (10) · Germany (9) · Thailand (7) · France (6) · India (6) · Japan (6) · Vietnam (5) · Costa Rica (4) · Russia (4) · South Africa (4) · Colombia (3) · Dominican Republic (3)
Chuanlin Wang, MD (2) · Anne Fiquet, MD (1) · Byeonguk Eun (1) · Dagmar Dilloo, MD, PhD (1) · Edison Alberto, MD (1) · HJ Jung (1) · Hanqing He (1) · Jong Hyun Kim (1) · Josefina Carlos, MD (1)
PMID 17716936, PMID 14670310, PMID 15882526, PMID 17090650, PMID 19095033, PMID 19117896, PMID 19952980, PMID 20189491, PMID 20439595, PMID 20950456, PMID 21219984, PMID 21441781, PMID 21807056, PMID 21817954, PMID 21945698, PMID 22001281, PMID 22157567, PMID 22273029, PMID 22349525, PMID 22475857, PMID 22531237, PMID 22691430, PMID 23032160, PMID 23783081, PMID 23966556, PMID 25765966, PMID 25882172, PMID 27288217, PMID 27510380, PMID 27846055, PMID 27846058, PMID 27879555, PMID 29576304, PMID 29789243, PMID 29960800, PMID 31307216, PMID 32048889, PMID 32307307, PMID 34931494, PMID 38582691, PMID 40628965, PMID 41144397, PMID 41276263, PMID 42483174, PMID 42688305
2015 (1), 2018 (1)